ADAM II IRB Approval

ADAM II IRB Notice of Approval_01-13-2010.pdf

Arrestee Drug Abuse Monitoring (ADAM II)

ADAM II IRB Approval

OMB: 3201-0016

Document [pdf]
Download: pdf | pdf
Institutional Review Board Notice of Approval
Principal Investigator/Project Director:
Project Title:

Arrestee Drug Abuse Monitoring Program (ADAM II)

Sponsor Agency:
Abt IRB #:

Dana Hunt

ONDCP

0239

Review Type:

Expedited

Approval Date

01/13/2010

Type of Approval:

Study Modification

Modification Number:

#003 (12/17/09)

Please note the following requirements:
The Board’s approval of this modification does not alter your responsibilities for the
project’s continuing review.
Problems or adverse reactions: If any problems in treatment of human subjects or unexpected
adverse reactions occur as a result of this study, you must notify the IRB Chairperson or IRB
Administrator immediately.
Consent forms: In the event the approved study includes procedures for written informed
consent, you only may use consent forms that bear the Abt Associates Inc. IRB approval stamp.
Renewal: You are required to apply for renewal of approval at least annually for as long as the
study is active. Your next review date should be on or before December 14, 2010.
Teresa Doksum
IRB Administrator
Cc:

Date:

January 13, 2010


File Typeapplication/pdf
File Modified2010-01-13
File Created2009-07-31

© 2024 OMB.report | Privacy Policy